Concepedia

Bhavana Bhatt

BB

Statistics

Publications

4

Citations

354

H-Index

4

Active since

2006

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

IRBM Science Park

Bhavana Bhatt is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, pharmacy, and medicinal chemistry.

Publications per year

2006–2021

4

Publications

4

A Series of Novel, Highly Potent, and Orally Bioavailable Next-Generation Tricyclic Peptide PCSK9 Inhibitors

Thomas J. Tucker, Mark W. Embrey, Candice Alleyne et al. · Journal of Medicinal Chemistry · 2021 · 152 citations · Full text

, , +17

Series of Novel and Highly Potent Cyclic Peptide PCSK9 Inhibitors Derived from an mRNA Display Screen and Optimized via Structure-Based Design

Candice Alleyne, Rupesh P. Amin, Bhavana Bhatt et al. · Journal of Medicinal Chemistry · 2020 · 128 citations · Full text

, , +14

Chemotherapy of leishmaniasis Part VI: Synthesis and bioevaluation of some novel terpenyl S,N- and N,N-acetals

S. N. Suryawanshi, Susmita Pandey, Rashmirathi et al. · European Journal of Medicinal Chemistry · 2006 · 39 citations

, , +12

Discovery of cell active macrocyclic peptides with on-target inhibition of KRAS signaling

Shuhui Lim, N. Boyer, Nicole Boo et al. · Chemical Science · 2021 · 35 citations · Full text

, , +15

1–4 of 4